HLA-B5 prevalence in patients with spondyloarthritis and impact on disease phenotype: a multicentric case-control study

Rheumatoid Arthritis

Impact of systemic inflammation and disease activity on the incidence of interstitial lung disease in patients with rheumatoid arthritis - a nested case-control study within the German biologics register RABBIT

Arthritis Res Ther

Ramien R, Rudi T, Alten R, Krause A, Schneider M, Schaefer M, Strangfeld A, Meissner Y

doi: 10.1186/s13075-024-03449-9

Further Publications Immunology

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study

Lancet

Ferrante M, D'Haens G, Jairath V, Danese S, Chen M, Ghosh S, Hisamatsu T, Kierkus J, Siegmund B, Bragg SM, Crandall W, Durand F, Hon E, Lin Z, Lopes MU, Morris N, Protic M, Carlier H, Sands BE, VIVID Study Group

doi: 10.1016/S0140-6736(24)01762-8

Further Publications Rheumatology

Prevalence and incidence of uveitis in patients with spondyloarthritis: the impact of the biologics era. Data from International ASAS-COMOSPA Study

Rheumatology (Oxford)

Maldonado-Ficco H, López-Medina C, Perez-Alamino R, Waimann CA, Maldonado-Cocco JA, Moltó A, Dougados M, Landewé RBM, van der Heijde D, van Den Bosch F

doi: 10.1093/rheumatology/keae536

Melanoma and Skin Cancer

Impact of particulate matter exposure on melanoma risk: A multicentre case-control study

J Eur Acad Dermatol Venereol

Bellinato F, Adami G, Reatini MA, Cattani G, Cannizzaro MV, Del Regno L, Peris K, Gisondi P, Girolomoni G

doi: 10.1111/jdv.20539

Rheumatoid Arthritis

Associations between loneliness, disease activity, and disease impact in inflammatory arthritis: A nationwide cross-sectional study among > 12,000 patients

Rheumatology (Oxford)

Vestergaard SB, Esbensen BA, Midtgaard J, Cromhout PF, Aadahl M, Glintborg B, de Thurah A

doi: 10.1093/rheumatology/keae471

Psoriatic Arthritis

Association of achieving clinical disease control criteria and patient-reported outcomes in bimekizumab-treated patients with active psoriatic arthritis: results from two phase III studies

Ther Adv Musculoskelet Dis

Kristensen LE, Tillett W, Nash P, Coates LC, Mease PJ, Ogdie A, Gisondi P, Ink B, Prickett AR, Bajracharya R, Taieb V, Lyris N, Lambert J, Walsh JA

doi: 10.1177/1759720X241288071

Further Publications Rheumatology

Association of Infant Breastfeeding and Spondyloarthritis: A Case-Control Study

J Rheumatol

Baggett K, Brandon TG, Xiao R, Weiss PF

doi: 10.3899/jrheum.2023-1203

Alopecia AreataAutoimmune Disease

Celiac Disease Associated with Alopecia Areata: A multicenter case control study

J Am Acad Dermatol

Alameddine R, Ahmad N, Alam Z, Pacha O

doi: 10.1016/j.jaad.2024.11.023

Autoimmune Disease

Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study